These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24909440)

  • 41. Antibiotics in primary care: focus on fluoroquinolones and other new and investigational antimicrobial agents.
    Pau AK; Slone RB
    Lippincotts Prim Care Pract; 1999; 3(1):39-54. PubMed ID: 10214201
    [No Abstract]   [Full Text] [Related]  

  • 42. Current challenges in the treatment of complicated urinary tract infections and prostatitis.
    Wagenlehner FM; Naber KG
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():67-80. PubMed ID: 16669930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The quinolones: decades of development and use.
    Emmerson AM; Jones AM
    J Antimicrob Chemother; 2003 May; 51 Suppl 1():13-20. PubMed ID: 12702699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The clinical consequences of antimicrobial resistance.
    Rice LB
    Curr Opin Microbiol; 2009 Oct; 12(5):476-81. PubMed ID: 19716760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Azithromycin in dentistry and oral surgery].
    Sasaki J
    Jpn J Antibiot; 2000 Jun; 53 Suppl B():117-24. PubMed ID: 12572095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fluoroquinolone antibiotics in infants and children.
    Schaad UB
    Infect Dis Clin North Am; 2005 Sep; 19(3):617-28. PubMed ID: 16102652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maximizing efficacy and reducing the emergence of resistance.
    Wise R
    J Antimicrob Chemother; 2003 May; 51 Suppl 1():37-42. PubMed ID: 12702702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-dose intravenous fluoroquinolones in the treatment of severe infections.
    Modai J
    J Chemother; 1999 Dec; 11(6):478-85. PubMed ID: 10678789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Fluoroquinolones, 10 years later].
    de la Blanchardière A; Carbon C
    Rev Prat; 1993 Sep; 43(14):1830-8. PubMed ID: 8310228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Widespread use of fluoroquinolones versus emerging resistance in pneumococci.
    Goldstein EJ; Garabedian-Ruffalo SM
    Clin Infect Dis; 2002 Dec; 35(12):1505-11. PubMed ID: 12471570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibiotic therapy for acute uncomplicated pyelonephritis in women. Take resistance into account.
    Prescrire Int; 2014 Dec; 23(155):296-300. PubMed ID: 25629148
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Editorial comment.
    Djavan B; Kazzazi A
    Urology; 2011 May; 77(5):1041-2; author reply 1042. PubMed ID: 21539955
    [No Abstract]   [Full Text] [Related]  

  • 53. Evolution toward high-level fluoroquinolone resistance in Francisella species.
    Sutera V; Levert M; Burmeister WP; Schneider D; Maurin M
    J Antimicrob Chemother; 2014 Jan; 69(1):101-10. PubMed ID: 23963236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Therapeutic use of fluoroquinolones].
    Lumio J
    Duodecim; 1999; 115(3):304-15. PubMed ID: 11830877
    [No Abstract]   [Full Text] [Related]  

  • 55. The use of fluoroquinolones in the treatment of skin infections.
    Martin SJ; Zeigler DG
    Expert Opin Pharmacother; 2004 Feb; 5(2):237-46. PubMed ID: 14996621
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluoroquinolone-resistant Vibrio cholerae isolated during a cholera outbreak in India.
    Krishna BV; Patil AB; Chandrasekhar MR
    Trans R Soc Trop Med Hyg; 2006 Mar; 100(3):224-6. PubMed ID: 16246383
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluoroquinolones: mechanism of action, classification, and development of resistance.
    Blondeau JM
    Surv Ophthalmol; 2004 Mar; 49 Suppl 2():S73-8. PubMed ID: 15028482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of carry-over of fluoroquinolones on the susceptibility of commensal Escherichia coli in the intestinal microbiota of poultry.
    Scherz G; Stahl J; Glünder G; Kietzmann M
    Berl Munch Tierarztl Wochenschr; 2014; 127(11-12):478-85. PubMed ID: 25872257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gatifloxacin Kyorin Pharmaceutical Co.
    Brown WM
    Curr Opin Investig Drugs; 2000 Sep; 1(1):35-44. PubMed ID: 11249593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluoroquinolone use in children.
    Sabharwal V; Marchant CD
    Pediatr Infect Dis J; 2006 Mar; 25(3):257-8. PubMed ID: 16511391
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.